Report Detail
Global Live Attenuated Vaccines Market Insights, Forecast to 2025
- RnM2352628 |
- 21 May, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated vaccine).
Examples of live attenuated) vaccines include: Viral: measles vaccine, mumps vaccine, rubella vaccine and live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), etc; Bacterial: BCG vaccine, oral typhoid vaccine and epidemic typhus vaccine.
The global Live Attenuated Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Live Attenuated Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of Live Attenuated Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Live Attenuated Vaccines in these regions.
This research report categorizes the global Live Attenuated Vaccines market by top players/brands, region, type and end user. This report also studies the global Live Attenuated Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GlaxoSmithKline
Merck
Pfizer
Astellas Pharma
Johnson & Johnson
CSL
Sanofi
Serum Institute Of India
Market size by Product
Bacterial
Viral
Market size by End User
Hospitals
Clinics
Research Institutes
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Live Attenuated Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Live Attenuated Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Live Attenuated Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Live Attenuated Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Live Attenuated Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Live Attenuated Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Live Attenuated Vaccines Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Live Attenuated Vaccines Market Size Growth Rate by Product
- 1.4.2 Bacterial
- 1.4.3 Viral
- 1.5 Market by End User
- 1.5.1 Global Live Attenuated Vaccines Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Research Institutes
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Live Attenuated Vaccines Market Size
- 2.1.1 Global Live Attenuated Vaccines Revenue 2014-2025
- 2.1.2 Global Live Attenuated Vaccines Sales 2014-2025
- 2.2 Live Attenuated Vaccines Growth Rate by Regions
- 2.2.1 Global Live Attenuated Vaccines Sales by Regions
- 2.2.2 Global Live Attenuated Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Live Attenuated Vaccines Sales by Manufacturers
- 3.1.1 Live Attenuated Vaccines Sales by Manufacturers
- 3.1.2 Live Attenuated Vaccines Sales Market Share by Manufacturers
- 3.1.3 Global Live Attenuated Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.2 Live Attenuated Vaccines Revenue by Manufacturers
- 3.2.1 Live Attenuated Vaccines Revenue by Manufacturers (2014-2019)
- 3.2.2 Live Attenuated Vaccines Revenue Share by Manufacturers (2014-2019)
- 3.3 Live Attenuated Vaccines Price by Manufacturers
- 3.4 Live Attenuated Vaccines Manufacturing Base Distribution, Product Types
- 3.4.1 Live Attenuated Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Live Attenuated Vaccines Product Type
- 3.4.3 Date of International Manufacturers Enter into Live Attenuated Vaccines Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Live Attenuated Vaccines Sales by Product
- 4.2 Global Live Attenuated Vaccines Revenue by Product
- 4.3 Live Attenuated Vaccines Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Live Attenuated Vaccines Breakdown Data by End User
6 North America
- 6.1 North America Live Attenuated Vaccines by Countries
- 6.1.1 North America Live Attenuated Vaccines Sales by Countries
- 6.1.2 North America Live Attenuated Vaccines Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Live Attenuated Vaccines by Product
- 6.3 North America Live Attenuated Vaccines by End User
7 Europe
- 7.1 Europe Live Attenuated Vaccines by Countries
- 7.1.1 Europe Live Attenuated Vaccines Sales by Countries
- 7.1.2 Europe Live Attenuated Vaccines Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Live Attenuated Vaccines by Product
- 7.3 Europe Live Attenuated Vaccines by End User
8 Asia Pacific
- 8.1 Asia Pacific Live Attenuated Vaccines by Countries
- 8.1.1 Asia Pacific Live Attenuated Vaccines Sales by Countries
- 8.1.2 Asia Pacific Live Attenuated Vaccines Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Live Attenuated Vaccines by Product
- 8.3 Asia Pacific Live Attenuated Vaccines by End User
9 Central & South America
- 9.1 Central & South America Live Attenuated Vaccines by Countries
- 9.1.1 Central & South America Live Attenuated Vaccines Sales by Countries
- 9.1.2 Central & South America Live Attenuated Vaccines Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Live Attenuated Vaccines by Product
- 9.3 Central & South America Live Attenuated Vaccines by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Live Attenuated Vaccines by Countries
- 10.1.1 Middle East and Africa Live Attenuated Vaccines Sales by Countries
- 10.1.2 Middle East and Africa Live Attenuated Vaccines Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Live Attenuated Vaccines by Product
- 10.3 Middle East and Africa Live Attenuated Vaccines by End User
11 Company Profiles
- 11.1 GlaxoSmithKline
- 11.1.1 GlaxoSmithKline Company Details
- 11.1.2 Company Business Overview
- 11.1.3 GlaxoSmithKline Live Attenuated Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 GlaxoSmithKline Live Attenuated Vaccines Products Offered
- 11.1.5 GlaxoSmithKline Recent Development
- 11.2 Merck
- 11.2.1 Merck Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Merck Live Attenuated Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Merck Live Attenuated Vaccines Products Offered
- 11.2.5 Merck Recent Development
- 11.3 Pfizer
- 11.3.1 Pfizer Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Pfizer Live Attenuated Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Pfizer Live Attenuated Vaccines Products Offered
- 11.3.5 Pfizer Recent Development
- 11.4 Astellas Pharma
- 11.4.1 Astellas Pharma Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Astellas Pharma Live Attenuated Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Astellas Pharma Live Attenuated Vaccines Products Offered
- 11.4.5 Astellas Pharma Recent Development
- 11.5 Johnson & Johnson
- 11.5.1 Johnson & Johnson Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Johnson & Johnson Live Attenuated Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Johnson & Johnson Live Attenuated Vaccines Products Offered
- 11.5.5 Johnson & Johnson Recent Development
- 11.6 CSL
- 11.6.1 CSL Company Details
- 11.6.2 Company Business Overview
- 11.6.3 CSL Live Attenuated Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 CSL Live Attenuated Vaccines Products Offered
- 11.6.5 CSL Recent Development
- 11.7 Sanofi
- 11.7.1 Sanofi Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Sanofi Live Attenuated Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Sanofi Live Attenuated Vaccines Products Offered
- 11.7.5 Sanofi Recent Development
- 11.8 Serum Institute Of India
- 11.8.1 Serum Institute Of India Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Serum Institute Of India Live Attenuated Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Serum Institute Of India Live Attenuated Vaccines Products Offered
- 11.8.5 Serum Institute Of India Recent Development
12 Future Forecast
- 12.1 Live Attenuated Vaccines Market Forecast by Regions
- 12.1.1 Global Live Attenuated Vaccines Sales Forecast by Regions 2019-2025
- 12.1.2 Global Live Attenuated Vaccines Revenue Forecast by Regions 2019-2025
- 12.2 Live Attenuated Vaccines Market Forecast by Product
- 12.2.1 Global Live Attenuated Vaccines Sales Forecast by Product 2019-2025
- 12.2.2 Global Live Attenuated Vaccines Revenue Forecast by Product 2019-2025
- 12.3 Live Attenuated Vaccines Market Forecast by End User
- 12.4 North America Live Attenuated Vaccines Forecast
- 12.5 Europe Live Attenuated Vaccines Forecast
- 12.6 Asia Pacific Live Attenuated Vaccines Forecast
- 12.7 Central & South America Live Attenuated Vaccines Forecast
- 12.8 Middle East and Africa Live Attenuated Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Live Attenuated Vaccines Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Live Attenuated Vaccines . Industry analysis & Market Report on Live Attenuated Vaccines is a syndicated market report, published as Global Live Attenuated Vaccines Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Live Attenuated Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
